Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection

The rgp120 HIV Vaccine Study Group

research article

Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection

Authors: The rgp120 HIV Vaccine Study Group
Publication date: 31 December 2005
Publisher
Doi

Abstract

The rgp120 HIV Vaccine Study Group (2005): Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection. The journal of infectious diseases 191: 654 -665, DOI: 10.5281/zenodo.114571

Similar works

Full text

ZENODO

oai:zenodo.org:1145711

Last time updated on 16/06/2018

This paper was published in ZENODO.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.